G-CSF

Type: Keyphrase
Name: G-CSF
First reported 2 hours ago - Updated 2 hours ago - 1 reports

Nora Therapeutics

By , Executive Editor, Life Science Leader magazineFollow Me On Twitter @WayneKobersteinThis company’s novel and lonely development of a new fertility drug belies the industry’s current uninterest in the field.SNAPSHOT is about the only game in town for ... [Published Life Science Leader - 2 hours ago]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

Worldwide market for biosimilars at its tipping point

Worldwide growth in the biosimilars market is hitting its tipping point, analysts say.Sales are projected to hit $25 billion by 2020, according to the folks over at BioWorld who put together a new report, “Biosimilars: A Global Perspective of a New Market.” ... [Published MedCity News - Sep 30 2014]
First reported Sep 27 2014 - Updated Sep 27 2014 - 1 reports

Leukocyte Population Dynamics and Detection of IL-9 as a Major Cytokine at the Mouse Fetal-Maternal Interface

IntroductionUnderstanding the intricate mechanisms regulating mammalian fetal-maternal interactions has remained a challenging goal for biologists for several decades [1] . During pregnancy, the maternal immune system faces the double task of protecting ... [Published Plosone.org - Sep 27 2014]
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

Forum Post: Good news?

My oncologist told me this morning that the chemo has worked really well after only three of the six planned cycles of carboplatin and paclitaxel. He was very pleased with my progress. Now I can decide to stop being treated and concentrate instead on ... [Published Macmillan Cancer Support - Sep 26 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Method for promoting muscle repair comprising administering G-CSF at the site of injury

The present invention relates to muscle repair promoters for local application that contain a colony-stimulating factor (CSF) as an active ingredient. The muscle repair promoters of the present invention exhibit their effect at low doses, particularly ... [Published Free Patents Online - Sep 23 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Leaders in Research & Scientific Sessions

There are a number of perennial destinations for the molecular imaging set that deliver cutting-edge research and promote clinical discussion, but, for many clinicians and researchers, the Society of Nuclear Medicine and Molecular Imaging’s Annual Meeting ... [Published MolecularImaging.net - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Penticton family fights to recover cancer drug costs

PENTICTON, BC – Shortly after their son’s first birthday, Aaron and Ana Moen received the devastating news that their boy has cancer.Aeson Moen is now 17-months old and entering his fifth cycle of chemotherapy this week.But the treatment doesn’t end ... [Published Global News Canada - Sep 16 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells

Reuters Health InformationBy Will Boggs MDSeptember 08, 2014NEW YORK (Reuters Health) - Researchers have found a new method to expand hematopoietic stem and progenitor cells ex vivo without genetic modification."We have now developed a novel approach ... [Published Diabetes Care - Sep 08 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor ...

HLA-haploidentical hematopoietic stem cell transplantation (HSCT) is suitable for patients lacking related or unrelated HLA-matched donors. Herein, we investigated whether plerixafor (MZ), as an adjunct to G-CSF, facilitated the collection of mega-doses ... [Published 7thSpace - Sep 02 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Granulocyte colony-stimulating factor off-target effect on nerve outgrowth promotes prostate cancer development - Abstract

The hematopoietic growth factor granulocyte colony-stimulating factor (G-CSF) has a role in proliferation, differentiation and migration of the myeloid lineage and in mobilizing hematopoietic stem and progenitor cells into the bloodstream.However, G-CSF ... [Published UroToday - Sep 02 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

G-CSF therapy improved survival in patients with alcoholic hepatitis

Patients with severe alcoholic hepatitis treated with standard therapy plus granulocyte colony-stimulating factor had a greater survival rate after therapy compared with those treated without it, according to data from a recent study.Forty-six patients ... [Published Orthopedics Today - Aug 26 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Research and Markets: World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others) 2013-2017

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xrwqsh/the_world_market) has announced the addition of the "The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others)" ... [Published Business Wire Health News - Jul 23 2014]

Quotes

According to our latest research report, " ", although the current biosimilars market is small, the future looks optimistic with number of innovative biologics going off patent. Our report discusses major trends and drivers in detail and the influence they will have on the market. Emerging markets will play the role of a major driver for the biosimilars market, which will be attributed to the local policies and the biosimilar attitude of the regions. The governments in the emerging economies are encouraging the growth of biosimilars by defining clear regulatory pathways."
"......The key findings of this study are the following: (i) autologous HSCT using apheresis products collected prior to infection is feasible in SHIV-infected RMs; (ii) as expected, the myeloablative TBI used for conditioning induced a massive reset of the lympho-hematopoietic compartment, consequently resulting in the depletion of 94.2-99.2% of circulating CD4+ T-cells; (iii) animals receiving autologous HSCT under ART exhibited a prompt and pronounced decline in the peripheral blood viral reservoir (with undetectable SHIV-DNA in PBMCs in two out of three RMs) and maintained undetectable SHIV-RNA viremia with the exception of a few minor blips; (iv) two of the three transplanted RMs showed a very rapid rebound of viremia after ART interruption; and (v) the third transplanted RM, who was sacrificed for clinical reasons at day fourteen post ART interruption, had no detectable virus in plasma, PBMCs, tonsils, and GI tract, low but detectable levels of SHIV-DNA in sorted peripheral CD4+ T-cells and lymph nodes, and moderate levels of SHIV-DNA in the spleen....."
The MIT/ICBP siRNA Database http:(//)web.mit.edu/sirna/-- "The MIT [Massachusetts Institute of Technology]/ICBP [Integrative Cancer Biology Program] siRNA Database is a university-wide effort to catalog these experimentally validated reagents and make that information available to other researchers, both within and outside the MIT community. (Massachusetts Institute of Technology)."
"The process of clinical development relates to creating a GMP-compliant process and scaled-up production of cells and proteins," Dr. Refaeli said. "In addition, we will need some toxicology studies on larger animals (dogs or pigs) for the proteins in order to obtain FDA approval to commence first-in-human clinical trials."

More Content

All (57) | News (47) | Reports (0) | Blogs (7) | Audio/Video (0) | Fact Sheets (2) | Press Releases (1)
sort by: Date | Relevance
Nora Therapeutics [Published Life Science Leader - 2 hours ago]
Global Biosimilar Market Outlook 2018 [Published Scottrade - 15 hours ago]
Worldwide market for biosimilars at its tipping... [Published MedCity News - Sep 30 2014]
Seattle Genetics and Takeda Announce Positive -2- [Published Scottrade - Sep 29 2014]
Leukocyte Population Dynamics and Detection of ... [Published Plosone.org - Sep 27 2014]
Persistence of Virus Reservoirs in ART-Treated ... [Published National AIDS Treatment Advocacy Project - Sep 26 2014]
Forum Post: Good news? [Published Macmillan Cancer Support - Sep 26 2014]
Molecular Hydrogen in Drinking Water Protects a... [Published Plosone.org - Sep 25 2014]
RNCOS - Business Consulting Services: Global Bo... [Published BusinessWeek - Sep 24 2014]
Method for promoting muscle repair comprising a... [Published Free Patents Online - Sep 23 2014]
Recombinant vectors [Published PharmCast - Sep 21 2014]
Recombinant Therapeutic Proteins Market & Pipel... [Published Global Information Inc - Sep 19 2014]
Recombinant Therapeutic Proteins Market & Pipel... [Published Individual.com - Sep 18 2014]
Leaders in Research & Scientific Sessions [Published MolecularImaging.net - Sep 16 2014]
Penticton family fights to recover cancer drug ... [Published Global News Canada - Sep 16 2014]
IL-10 and NOS2 Modulate Antigen-Specific Reacti... [Published Plosone.org - Sep 12 2014]
Paying it forward on ‘orphan disease’ Fanconi A... [Published Philippine Daily Inquirer - Sep 11 2014]
Filgrastim BLA Approval Nears; Hospitals Ready? [Published Pharmacy Practice News - Sep 09 2014]
Ex Vivo Expansion of Hematopoietic Stem and Pro... [Published Diabetes Care - Sep 08 2014]
Two Presentations at International Conferences ... [Published PipelineReview - Sep 04 2014]
Mobilization of healthy donors with plerixafor ... [Published 7thSpace - Sep 02 2014]
Granulocyte colony-stimulating factor off-targe... [Published UroToday - Sep 02 2014]
Mutation disables innate immune system [Published Medical Xpress - Aug 29 2014]
Early Activation of MAP Kinases by Influenza A ... [Published Plosone.org - Aug 28 2014]
Green Cross Neulapeg biosimilar approved in Sou... [Published Pharma Letter - Aug 28 2014]
South Korean FDA Approval For Green Cross’ Neul... [Published Asian Scientist - Aug 27 2014]
G-CSF therapy improved survival in patients wit... [Published Orthopedics Today - Aug 26 2014]
Stem Cell Transplantation [Published Multiple Sclerosis Research - Aug 17 2014]
Intracutaneous paste composition [Published PharmCast - Aug 12 2014]
Autologous hematopoietic stem cell transplantat... [Published Multiple Sclerosis Journal RSS feed -- OnlineFi ... - Jul 30 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Stem Cell Transplantation [Published Multiple Sclerosis Research - Aug 17 2014]
Greco R, Bondanza A, Oliveira MC, Badoglio M, Burman J, Piehl F, Hagglund H, Krasulova E, Simões BP, Carlson K, Pohlreich D, Labopin M, Saccardi R, Comi G, Mancardi GL, Bacigalupo A, Ciceri F, Farge D. Autologous hematopoietic stem cell transplantation ...
Autologous hematopoietic stem cell transplantat... [Published Multiple Sclerosis Journal RSS feed -- OnlineFi ... - Jul 30 2014]
Background: Neuromyelitis optica (NMO) is an inflammatory autoimmune disorder of the central nervous system, hallmarked by pathogenic anti-aquaporin 4 antibodies. NMO prognosis is worse compared with multiple sclerosis. Objective: The European Group for ...
Research and Markets: World Market for Biosimil... [Published Business Wire Health News - Jul 23 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xrwqsh/the_world_market) has announced the addition of the "The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others)" ...
The World Market for Biosimlars (EPO, G-CSF, HG... [Published PR Newswire: Entertainment & Media - Jul 21 2014]
LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th... ...
Research and Markets: The World Market for Bios... [Published Business Wire Health News - Jun 06 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xp9knh/the_world_market) has announced the addition of the "The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, ...
1 2

Press Releases

sort by: Date | Relevance
Neumedicines Publishes Data Demonstrating that ... [Published GlobeNewswire: Sports News - Jun 02 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.